African Nations Unite in Groundbreaking HIV Vaccine Initiative

Eight African countries have launched a pioneering HIV vaccine research initiative under the "Bringing Innovation to Clinical and Laboratory Research to End HIV in Africa through New Vaccine Technology" (BRILLIANT) program. With a $45 million grant from the U.S. Agency for International Development (USAID), the initiative aims to accelerate HIV vaccine development through cutting-edge science and technology as part of the HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) program.   The BRILLIANT consortium involves Nigeria, South Afr...